Genlantis Diagnostics, Inc
UnclaimedIn-Vitro Diagnostic Substance ManufacturingSan Diego, CA
Founded
2019
Primary NAICS
325413
CAGE code
8KGH8
Federal awards
—
Overview
Genlantis Diagnostics is developing HepBQuik and TriQuik: rapid multiplex lateral-flow tests for hepatitis B, hepatitis C and HIV screening.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- In-Vitro Diagnostic Substance Manufacturing325413
Capabilities
Analytical Laboratory Instrument ManufacturingSurgical and Medical Instrument ManufacturingResearch and Development in Biotechnology (except Nanobiotechnology)Drugs and BiologicalsLaboratory Equipment and SuppliesGeneral Science & Technology R&D Svcs; General Science & Technology; Experimental DevelopmentGeneral Science and Technology R&D Services; General Science and Technology; R&D Administrative ExpensesGeneral Science & Technology R&D Svcs; General Science & Technology; R&D Facilities & Maj Equip